1. Health Insurance Review and Assessment Service. Guidelines on economic evaluation for pharmaceuticals. 2021. https://www.hira.or.kr/bbsDummy.do?pgmid=HIRAA040055000000. Accessed 20 May 2021.
2. Bae EY, Lee EK. Pharmacoeconomic guidelines and their implementation in the Positive List System in South Korea. Value Health. 2009;12:S36-41.
3. Bae SJ, Lee SO, Bae EY, Jang SM. Korean guidelines for pharmacoeconomic evaluation (second and updated version). Pharmacoeconomics. 2013;31:257–67.
4. Lee TJ, Bae EY, Kang EJ, Bae SJ, Ahn H, Cho M, Han S, Hong J. Recommendations for the revision of pharmacoeconomic guidelines (in Korean). Seoul: Seoul National University; 2019.
5. HIRA. 2018 TF report for the improvement of economic evaluation system (in Korean). Wonju: Health Insurance Review and Assessment Service; 2018.